Efgartigimod demonstrated superior efficacy over IVIG in improving MG-ADL and QMG scores in myasthenia gravis patients. Patients treated with efgartigimod experienced faster symptom improvement and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback